| Date Filed | Type | Description |
| 10/03/2023 |
4
| Leproust Emily M. (CEO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 1,122 shares
@ $20.26, valued at
$22.7k
|
|
| 08/22/2023 |
4
| Leproust Emily M. (CEO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 2,787 shares
@ $19.46, valued at
$54.2k
|
|
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2023 |
4
| Leproust Emily M. (CEO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 1,122 shares
@ $20.46, valued at
$23k
|
|
| 05/23/2023 |
4
| Leproust Emily M. (CEO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 2,754 shares
@ $13.03, valued at
$35.9k
Granted 64,950 options to buy
@ $67.85, valued at
$4.4M
|
|
| 05/08/2023 |
4
| Leproust Emily M. (CEO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Exercised 24,360 options to buy
@ $5.95, valued at
$144.9k
|
|
| 05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| Leproust Emily M. (CEO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 1,121 shares
@ $15.08, valued at
$16.9k
|
|
| 03/21/2023 |
4
| Leproust Emily M. (CEO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 1,748 shares
@ $16.51, valued at
$28.9k
|
|
| 02/22/2023 |
4
| Leproust Emily M. (CEO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 2,741 shares
@ $22.52, valued at
$61.7k
|
|
| 01/26/2023 |
4
| Leproust Emily M. (CEO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 980 shares
@ $28.74, valued at
$28.2k
|
|
| 01/05/2023 |
4
| Leproust Emily M. (CEO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 628 shares
@ $23.81, valued at
$15k
Paid exercise price by delivering 490 shares
@ $23.81, valued at
$11.7k
|
|
| 12/21/2022 |
4
| Leproust Emily M. (CEO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Granted 59,758 shares
@ $0 |
|
| 11/22/2022 |
4
| Leproust Emily M. (CEO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 2,762 shares
@ $24.81, valued at
$68.5k
|
|
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2022 |
4
| Leproust Emily M. (President & CEO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 627 shares
@ $35.24, valued at
$22.1k
Paid exercise price by delivering 486 shares
@ $35.24, valued at
$17.1k
|
|
| 08/23/2022 |
4
| Leproust Emily M. (President & CEO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 2,812 shares
@ $42.81, valued at
$120.4k
|
|
| 07/26/2022 |
4
| Leproust Emily M. (President & CEO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 913 shares
@ $43.52, valued at
$39.7k
|
|
| 07/06/2022 |
4
| Leproust Emily M. (President & CEO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 1,111 shares
@ $37.08, valued at
$41.2k
|
|
| 05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| Leproust Emily M. (Director) has filed a Form 4 on Sema4 Holdings Corp.|
Txns:
| Exercised 12,836 restricted stock units
@ $0 |
|
| 05/06/2022 |
4/A
| Leproust Emily M. (Director) has filed a Form 4 on Sema4 Holdings Corp.|
Txns:
| Granted 78,914 options
@ $0 |
|
| 05/04/2022 |
4
| Leproust Emily M. (Director) has filed a Form 4 on Sema4 Holdings Corp.|
Txns:
| Granted 78,914 options to buy
@ $2.155, valued at
$170.1k
Granted 45,454 restricted stock units
@ $0 |
|
| 04/26/2022 |
4
| Leproust Emily M. (President & CEO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 923 shares
@ $34.21, valued at
$31.6k
|
|
| 04/05/2022 |
4
| Leproust Emily M. (President & CEO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 1,108 shares
@ $52.91, valued at
$58.6k
|
|
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2022 |
4
| Leproust Emily M. (President & CEO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 1,008 shares
@ $55.87, valued at
$56.3k
|
|
| 01/20/2022 |
4
| Leproust Emily M. (President & CEO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Sold 286 shares
@ $60.0318, valued at
$17.2k
Paid exercise price by delivering 579 shares
@ $77.39, valued at
$44.8k
Exercised 286 options to buy
@ $8.82, valued at
$2.5k
|
|
| 12/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2021 |
4
| Leproust Emily M. (President & CEO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 2,829 shares
@ $110.62, valued at
$312.9k
|
|
| 11/17/2021 |
4
| Leproust Emily M. (President & CEO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Sold 3,764 shares
@ $114.733, valued at
$431.9k
Sold 6,676 shares
@ $115.6844, valued at
$772.3k
Exercised 10,440 options to buy
@ $5.95, valued at
$62.1k
|
|
|